I'm not arguing that it reduces hypos. That's no argument really. In the quote you used, hypo wasn't mentioned once.
I'm actually arguing that it allows you to use MDI like a pump and manage your diabetes to a much flatter blood glucose curve. All at a hugely lower cost than fitting everyone with a pump/cgm.
In theory, at least, (according to all good endos) this reduces the long run complications significantly and saves the NHS masses of money while keeping the individual as a tax generator rather than a benefit consumer, benefitting the economy as well.